We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HHS:NASDAQHarte Hanks, Inc. Analysis

Data as of 2026-09-30 - not real-time

$4.63

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Harte Hanks, Inc. is bullish at $4.63, with short-term averages leading the long-term ones. The last 30 days have gained 10.8%. RSI sits at 71.2, which reads as overbought, and MACD momentum is bearish. Recent trading has carved out support near $4.14 and resistance around $4.67.
Multiples put this in undervalued territory: 4.3 times earnings against the sector's 27.5.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 41.6%, a beta of 0.57 and a maximum drawdown of 48.8%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

CHELMSFORD, MA / ACCESS Newswire / September 15, 2026 / Harte Hanks, Inc.Detailed price information for Harte-Hanks HHS-Q from The Globe and Mail including charting and trades.Morningstar%2c Inc.1mon$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 71.2 signals overbought conditions
  • Trading above the 200-day average of 2.95

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 71.2 signals overbought conditions
  • P/E of 4.3 versus sector average of 27.5

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 4.3 versus sector average of 27.5
  • Negative profit margin of -3.7%
  • Negative return on equity of -30.4%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.70%
Profit Margin-3.70%
P/E Ratio4.3
ROE-30.41%
ROA-3.38%
Debt/Equity156.60
P/B Ratio2.2
Op. Cash Flow$1.3M
Free Cash Flow$4.5M
Industry P/E27.5

Technical Analysis

TrendBullish
RSI71.2
Support$4.14
Resistance$4.67
MA 20$4.44
MA 50$3.60
MA 200$2.95
MACDBearish
VolumeDecreasing
Fear & Greed Index92.8

Valuation

Fair Value$4.67
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.57
Volatility41.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.